SARS-CoV-2 viral shedding and transmission dynamics: implications of WHO COVID-19 discharge guidelines
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2021
TITLE AUTHOR(S): K.Badu, K.Oyebola, J.Z.B.Zahouli, A.F.Fagbamigbe, D.K.De Souza, N.Dukhi, E.F.Amankwaa, M.F.Tolba, A.A.Sylverken, L.Mosi, P.K.Mante, D.Matoke-Muhia, N.Goonoo
KEYWORDS: COVID-19, TRANSMISSION OF DISEASE, WORLD HEALTH ORGANISATION (WHO)
DEPARTMENT: Human and Social Capabilities (HSC)
Print: HSRC Library: shelf number 12098
HANDLE: 20.500.11910/16377
URI: http://hdl.handle.net/20.500.11910/16377
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
The evolving nature of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has necessitated periodic revisions of COVID-19 patient treatment and discharge guidelines. Since the identification of the first COVID-19 cases in November 2019, the World Health Organization (WHO) has played a crucial role in tackling the country-level pandemic preparedness and patient management protocols. Among others, the WHO provided a guideline on the clinical management of COVID-19 patients according to which patients can be released from isolation centers on the 10th day following clinical symptom manifestation, with a minimum of 72 additional hours following the resolution of symptoms. However, emerging direct evidence indicating the possibility of viral shedding 14 days after the onset of symptoms called for evaluation of the current WHO discharge recommendations. In this review article, we carried out comprehensive literature analysis of viral shedding with specific focus on the duration of viral shedding and infectivity in asymptomatic and symptomatic (mild, moderate, and severe forms) COVID-19 patients. Our literature search indicates that even though, there are specific instances where the current protocols may not be applicable (such as in immune compromised patients there is no strong evidence to contradict the current WHO discharge criteria.-
Related Research Outputs:
- Editorial: the utility of 2009 H1N1 pandemic data in understanding the transmission potential and estimating the burden of COVID-19 in South Africa to guide mitigation strategies
- Correlating WHO COVID-19 interim guideline 2020.5 and testing capacity, accuracy, and logistical challenges in Africa
- Implications of WHO COVID-19 interim guideline 2020.5 on the comprehensive care for infected persons in Africa: Before, during and after clinical management of cases
- Quality Tuberculosis care begins with people-centred approaches and education
- Influence of the WHO framework convention on tobacco control on tobacco legislation and policies in sub-Saharan Africa
- Letter to the editor: COVID-19 and Tuberculosis in South Africa: a dangerous combination
- Projecting the likely impact of COVID-19 on food and nutrition security in South Africa
- Water in the time of COVID-19
- Aligning knowledge, skills and capabilities across South Africa's health innovation system to combat COVID-19
- Tuberculosis in the context of the COVID-19 pandemic in South Africa
- Viral (un)freedom in the area of COVID-19: it is all about trust
- Not a 'skop, skiet en donner' moment: defence force deployment in the time of COVID-19
- Exploiting COVID-19 to spread hatred and fear: South Africa is vulnerable
- Living through global trauma: why South Africa needs a public mental-health response to COVID-19
- SA's hand hygiene strategy: the COVID-19 curve ball
- COVID-19: lessons in remote learning from China and Europe
- Running remote seminars in a time of COVID-19
- The COVID-19 impact on sexual- and reproductive-health rights and gender based violence
- Macroeconomic stimulus packages and inequality in developing countries: lessons from the 2007-2009 crisis for South Africa
- The need for universal health care: what COVID-19 may teach us